Advisory Board and Editors Genomics
Hugo Sarmento
Professor in the Department of Hydrobiology of the Universidade Federal of São Carlos (UFSCar). Head of the Laboratory of Microbial Processes and Biodiversity, my research area is aquatic microbial ecology, with emphasis on biotic interactions, structure and function of planktonic communities in all compartments of the food web (viruses, bacteria, phytoplankton, zooplankton) mainly in tropical aquatic environments.
Darren N Saunders
Senior Lecturer in Medicine at the University of NSW and visiting fellow at the Kinghorn Cancer Centre, Garvan Institute in Sydney, Australia. Science communicator and past deputy chair of the Australian Academy of Science Early-Mid Career Researcher Forum. Australian Leadership Award (2012), NSW Life Scientist Research Award (2010).
My research is focused on proteostasis and metabolic reprogramming in cancer and neurodegeneration, integrating various platforms (including proteomics, genomics, and metabolomics) to better understand genotype-phenotype relationships. I have a long-standing interest in protein homeostasis (proteostasis), publishing numerous manuscripts providing mechanistic insights into serpin biology and the Ubiquitin-proteasome system, with more recent work aimed at characterising novel mutations involved in protein misfolding and Ub systems in various disease states. I developed a novel platform for screening protein-protein interactions in situ, and novel proteomics approaches to systematically identify E3 Ub ligase substrates and for exploring interactome diversity in cell signalling. We use a number of models systems including patient-derived iPS cells, patient derived tumour xenografts and transgenic models of cancer and neurodegeneration. I am also collaborating to develop creative technology-based approaches to visualizing and communicating complex data, using music to explore the intersection between genetics and environment.
Primo Schär
PhD University of Berne, Switzerland with Prof. J. Kohli; Research focus: Yeast genetics, mechanisms of meiotic recombination.
Postdoctoral fellow at the University of Berne, Switzerland with Prof. J. Kohli; Research focus: Yeast genetics and DNA Mismatch Repair in Meiotic Recombination.
Postdoctoral fellow at the Imperial Cancer Research Fund (Cancer Research UK), London UK, with Prof. Tomas Lindahl; Research focus: Function of DNA ligases in yeast and mammalian DNA repair, DNA base excision repair.
Junior research group leader at the Institute of Molecular Cancer Research, University of Zürich, Switzerland; Research focus: Genome Stability, DNA double strand-break repair and DNA base excision repair in yeast and mammalian cells.
Since 2003 Professor and research group leader at the Department of Biomedicine, University of Basel, Switzerland; Research focus: Molecular mechanisms underlying (Epi)Genome plasticity in stem cells, DNA base excision repair in DNA demethylation and cell fate programming.
Alexander Schliep
Alexander Schliep received a PhD degree in computer science from the Center for Applied Computer Science (ZAIK/ZPR) at the Universität zu Köln, Germany (2001), working in collaboration with the Theoretical Biology and Biophysics Group (T-10) at Los Alamos National Laboratory. From 2002-2009 he was the group leader of the Bioinformatics Algorithms Group in the Department for Computational Molecular Biology at the Max Planck Institute for Molecular Genetics in Berlin. From 2009–2016 he held a joint position as associate professor in the Department of Computer Science and the BioMaPS Institute for Quantitative Biology. From August 2016–February 2025 he held a faculty position (part-time since Oct 2022) at the University of Gothenburg in the Department of Computer Science and Engineering, which is a joint department of Chalmers and the University of Gothenburg. Since October 2022 he is the chair for medical bioinformatics at the Faculty of Health Sciences Brandenburg. His group is located at the Brandenburg Technical University Cottbus-Senftenberg.
He serves as an associate editor for BMC Bioinformatics and as an editor of PeerJ.
Joao C Setubal
João Setubal is full professor in the Biochemistry Department of the Institute of Chemistry at the University of São Paulo, Brazil. Setubal has a PhD in Computer Science (1992) from the University of Washington (USA). He was a faculty member at the University of Campinas (Unicamp, Brazil) (1992-2004), then Associate Professor at the Biocomplexity Institute of Virginia Tech, USA (formerly the Virginia Bioinformatics Institute) (2004-2011), where he still is an Adjunct Faculty. His research interests are in computational tools for genomics, metagenomics, and transcriptomics, and applications of such tools primarily in microbiology and microbial ecology.
Yuan Shang
Dr. Yuan Shang works on Alzheimer's Disease (AD) at the University of Arizona. He combines any potential methods and data to search potential therapeutic opportunities for AD. He is an expert on omics data analysis, multi-omics integrations, network-based pattern recognition, and machine learning-based biomarker discoveries.
Katsuhiko Shirahige
Professor, Laboratory of Genome Structure and Function, Institute of Molecular and Cellular Biosciences, The University of Tokyo.
Director of Research Center for Epigenetic Disease, The University of Tokyo
Joana C Silva
My group applies evolutionary genetics and genomic sciences to basic research on species evolution and translational research of infectious diseases. I have been studying infectious disease genomics since the early 2000's. At The Institute for Genomic Research (TIGR) I was part of the team that launched the field of parasite genomics, with work on several Plasmodium and trypanosomatid species, Theileria parva and Trichomonas vaginalis. At the Institute for Genome Sciences, University of Maryland School of Medicine, we have ongoing projects on a variety of parasites in the phylum Apicomplexa. These include the causative agents of malaria in humans (genus Plasmodium), tropical theileriosis and East Coast fever in cattle (genus Theileria), human babesiosis (genus Babesia), and human cryptosporidiosis (genus Cryptosporidium). Ongoing projects include the study of species biology and the nature of host-parasite interactions, based on the generation and analyses of genomes, and studies of vaccine efficacy and vaccine design, drug resistance and the evolution of parasite populations, informed by population genomics data. Our research is funded by NSF, NIH, USDA and the Bill and Melinda Gates Foundation.
Alison J Sinclair
BSc in Biochemistry from UCL London UK; PhD Cancer Virology at the Imperial Cancer Research Fund, London UK; post-doctoral fellowship at the European Molecular Biology Laboratory in Heidelberg, Germany, researching transcription; post-doctoral fellowship and assistant member of staff at the Ludwig Institute for Cancer Research in London, investigating a transcription factor network in Epstein-Barr virus and cell cycle regulation. Faculty School of Life Sciences at the University of Sussex, UK.
Amit Singh
Dr. Singh received his B.Sc. from the Government Degree College Nahan, H.P. University, India and his M.Sc. and Ph.D from Devi Ahilya University, Indore, India. After a short stint as a Research Associate in the field of Trangenics of silkworm, Bombyx mori, in Indian Institute of Sciences (IISc.), Bangalore, India, Dr. Singh moved to Academic Sinica Taiwan to pursue post doctoral research in the field of eye development using Drosophila melanogaster model system. In 2002, Dr. Singh moved to Baylor College of Medicine, Houston, Texas to further pursue his work on Drosophila eye development and was promoted to an instructor (non-tenure track faculty) position in 2004. Dr. Singh was hired at University of Dayton as a tenure track assistant professor in 2007 and promoted to associate professor in 2013. To date, he has published one book and 52 papers.
Himanshu Singh
Presently, I am working as a Senior Research Scientist at Memorial Sloan Kettering Cancer Center, New York, USA. My research interest includes “epigenetics and transcriptional regulation”. My research work is focused on exploring microenvironment of high-grade tumors arise in the overall course of the disease and in relation to treatment.
During 2021-22, I worked as Postdoctoral Research Scientist at Columbia University, New York, US. My work was to explore differences between regulatory networks involved in cancer and normal tissues using bioinformatics and computational biology. Earlier, I was working as Post-Doc at TAGC, INSERM, Aix Marseille University, Marseille, France during 2018-21. My research work was focused on the Identification of Epromoters, promoters showing enhancer activity, like clusters in various stress conditions. We have developed a pipeline to identify Epromoter like clusters. During 2016-18, I worked as Research Associate at CSIR-Institute of Genomics & Integrative Biology, New Delhi, India. My work was focused on the identification and validation of genetic and epigenetic biomarkers for high altitude phenotypes using bioinformatics approaches. I pursued my Ph.D. work at the Department of Biochemistry, All India Institute of Medical Sciences (AIIMS), New Delhi, India, and earned my Ph.D. degree from NIU, India in 2016.
In my tenure, I have published around FIFTY Articles. In addition to this, I was awarded an Independent Research Project from the Indian Council of Medical Research, India. I was also an Invited Researcher (two times) at the Department of Medical Chemistry, Medical University of Vienna, Vienna, Austria. I was also awarded various travel grants from Indian and overseas funding agencies to present my research work.
Reema Singh
A highly accomplished Computational Biologist and Bioinformatician with over 19 years of research expertise. My professional focus is on One Health bioinformatics, using pathogen transcriptomics and genomic surveillance to investigate and control infectious threats and antimicrobial resistance. My career has been marked by a strong track record of developing impactful tools and pipelines, including the Dlact antimicrobial resistance gene database and the Gen2Epi computational pipeline. Currently, as a Bioinformatician and Data Manager at the Vaccine and Infectious Disease Organization (VIDO), I apply my skills to analyze large-scale transcriptomics data and elucidate host-pathogen interactions in both human and animal populations